COMPARATIVE BIOAVAILABILITY OF ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE ADMINISTERED IN FREE COMBINATION AND IN A FIXED TRIPLE FORMULATION DESIGNED FOR DAILY USE IN ANTITUBERCULOSIS CHEMOTHERAPY .1. SINGLE-DOSE STUDY

被引：30

作者：

ACOCELLA, G

NONIS, A

GIALDRONIGRASSI, G

GRASSI, C

机构：

来源：

AMERICAN REVIEW OF RESPIRATORY DISEASE | 1988年 / 138卷 / 04期

关键词：

D O I：

10.1164/ajrccm/138.4.882

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：882 / 885

页数：4

共 10 条

[1]

ACOCELLA G, 1985, AM REV RESPIR DIS, V132, P510

ACOCELLA, G ;

BONOLLO, L ;

TENCONI, LT ;

GARIMOLDI, M ;

MAINARDI, M ;

NICOLIS, FB .

[3]

ACOCELLA G, 1986, AM REV RESPIR DIS, V134, P1283

[4]

ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076

[5]

ESCREET BC, 1981, S AFR MED J, V60, P951

[6]

GIBALDI M, 1982, PHARMACOKINETICS

[7]

OLSON WA, 1977, CLIN CHEM, V23, P745

[8]

PARROT R, 1983, REV FR MAL RESPIR, V11, P705

[9]

Riess W, 1968, S RIMACTANE, P36

[10]

SBARBARO JA, 1986, AM REV RESPIR DIS, V134, P1109